Regulation And Legal
Supreme Court Dismisses Appeal Against Agastya Biopharm
Supreme Court upheld NCLAT judgment dated 22 April 2026 in Company Appeal (AT)(CH) No.48/2026, dismissing appellant's challenge.
The appeal filed by D. Aravindakshan Kovilakom was rejected, and any pe
